Search
for
Sort by
Research 511–540 of 1000+
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- Metabolic risk in PCOS: phenotype and adiposity impact
- Oestrogen functions in skin and skin appendages
- ACNE
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Gender-Affirming Hormone Therapy for Transgender Females
- Endocrine correlates of male breast cancer risk: a case-control study in Athens, Greece
- Gender-Affirming Hormone Therapy for Transgender Men
- CLINICAL UPDATES IN HAIR
- Skin and glucocorticoids: effects of local skin glucocorticoid impairment on skin homeostasis
- Low serum testosterone is associated with an increased risk of first-time renal calculi in men without testosterone replacement therapy
- Male‐pattern baldness, common latent viruses, and microcompetition
- A case of severe hyperandrogenism, acanthosis nigricans and overt diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management
- The Quantification of Terminal Hair by Digital Microscopy: Advancements Towards a More Objective Diagnosis of Hirsutism
- The skin and obesity
- Evaluation of Socio-demographic and Clinical Profiles among Women with Polycystic Ovary Syndrome (PCOS) in Kushtia
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Androgen treatment in women
- Clinical profile and lifestyle factors in women with different severities of hirsutism
- Androgenetska alopecija u žena
- Alopecia areata – hyperactivity of the hypothalamic–pituitary–adrenal axis is a myth?
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Alopecia Areata
- Treatment of Hair Loss
- The diagnosis of polycystic ovary syndrome in adolescents
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- Adult polycystic ovary syndrome begins in childhood
- 9 Role of 5α-reductase in health and disease
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Dermatologic manifestations of endocrine disorders